Peptide News

A static news aggregator refreshed from FDA MedWatch, PubMed, and ClinicalTrials.gov so the site can surface real signal without inventing headlines.

Latest sync: Nov 21, 2026, 12:27 PM. This page favors official and public primary sources over generic news scraping.

Display order is chronological from newest to oldest; future-dated or recently indexed items are pushed to the end.

FDA safety feed
3

Status: live

PubMed research watch
12

Status: live

ClinicalTrials.gov updates
11

Status: live

Tracked topics
retatrutidecompoundedcompoundingobesitytirzepatideglp-1semaglutidebpc-157

Newest peptide and GLP-1 updates

A rolling stream of the most recent official and public-source items in the tracker. Future-dated PubMed indexing artifacts stay at the bottom.

PubMed Research

Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis.

Rapid Commun Mass Spectrom • Retatrutide • Journal Article

RetatrutideJournal Article
recently indexed Indexed ahead of issue date
FDA.gov What's New: Drugs

Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Sterile Products Due to Lack of Sterility Assurance

FOR IMMEDIATE RELEASE - Tomball, Texas – November 20, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of compounded sterile products that remain within their beyond-use dates to the consumer level, including some products that were compounded by Greenwich Rx

compoundedcompounding
19 hours ago Nov 20, 2026
ClinicalTrials.gov Trials

Effects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity

RECRUITING • University Medical Centre Ljubljana

INTERVENTIONALRECRUITINGTirzepatide
2 days ago Nov 20, 2026
ClinicalTrials.gov Trials

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

COMPLETED • Eli Lilly and Company

COMPLETEDINTERVENTIONALTirzepatide
2 days ago Nov 20, 2026
ClinicalTrials.gov Trials

GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward

NOT_YET_RECRUITING • University of Minnesota

INTERVENTIONALNOT_YET_RECRUITINGSemaglutide
2 days ago Nov 20, 2026
ClinicalTrials.gov Trials

A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy

ACTIVE_NOT_RECRUITING • Novartis

ACTIVE_NOT_RECRUITINGOBSERVATIONALSemaglutideTirzepatide
2 days ago Nov 20, 2026
ClinicalTrials.gov Trials

Semaglutide in Alcohol Use Disorder

NOT_YET_RECRUITING • University of Minnesota

INTERVENTIONALNOT_YET_RECRUITINGSemaglutide
3 days ago Nov 19, 2026
PubMed Research

Popularity Without Proof: A Narrative Review of Peptide Adjuncts to Testosterone Therapy in Body Composition and Functional-Driven Use.

Am J Mens Health • BPC-157 • Journal Article

BPC-157Journal ArticleReview
3 days ago Nov 19, 2026
PubMed Research

Chatbots and Social Media-Embedded AI Assistants Provide Inconsistent Information on the Use of Unregulated Peptides Marketed for Musculoskeletal Recovery.

HSS J • BPC-157 • Journal Article

BPC-157Journal Article
3 days ago Nov 19, 2026
ClinicalTrials.gov Trials

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

ACTIVE_NOT_RECRUITING • Eli Lilly and Company

ACTIVE_NOT_RECRUITINGINTERVENTIONALRetatrutide
5 days ago Nov 17, 2026
PubMed Research

New-onset depersonalization-derealization syndrome following semaglutide therapy.

JCEM Case Rep • Semaglutide • Case Reports

SemaglutideCase ReportsJournal Article
5 days ago Nov 17, 2026
ClinicalTrials.gov Trials

Effect of Retatrutide Versus Placebo in Participants Who Have Obesity or Are Overweight

RECRUITING • Hudson Biotech

INTERVENTIONALRECRUITINGRetatrutide
10 days ago Nov 12, 2026
ClinicalTrials.gov Trials

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease

RECRUITING • Hudson Biotech

INTERVENTIONALRECRUITINGTesamorelin
10 days ago Nov 12, 2026
PubMed Research

Detecting GHRH Analogue Tesamorelin and Its Metabolites in Post-Administration Human Urine and Serum Using LC-HRMS/MS.

Drug Test Anal • Tesamorelin • Journal Article

TesamorelinJournal Article
11 days ago Nov 11, 2026
ClinicalTrials.gov Trials

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

ACTIVE_NOT_RECRUITING • Eli Lilly and Company

ACTIVE_NOT_RECRUITINGINTERVENTIONALRetatrutide
12 days ago Nov 10, 2026
PubMed Research

GLP-1 based therapy of obesity and type 2 diabetes.

Diabetol Int • Tirzepatide • Journal Article

TirzepatideSemaglutideJournal ArticleReview
12 days ago Nov 10, 2026
FDA.gov MedWatch Safety Alerts

MedWatch Alert: FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication

FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication

peptideglp-1
13 days ago Nov 9, 2026
ClinicalTrials.gov Trials

Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury

RECRUITING • Johns Hopkins University

INTERVENTIONALRECRUITINGTesamorelin
13 days ago Nov 9, 2026
PubMed Research

Weight management in people with HIV.

Lancet HIV • Tesamorelin • Journal Article

TesamorelinJournal ArticleReview
14 days ago Nov 8, 2026
PubMed Research

Baseline monocyte GIP receptor mRNA expression is associated with reductions in body weight and FIB-4 index after switching to tirzepatide in patients with type 2 diabetes.

Diabetol Int • Tirzepatide • Journal Article

TirzepatideJournal Article
22 days ago Oct 31, 2026
PubMed Research

The GLP-1 receptor agonist semaglutide reduces alcohol consumption and anxiety-like behaviors during withdrawal in Marchigian Sardinian alcohol-preferring rats.

Neuropharmacology • Semaglutide • Journal Article

SemaglutideJournal Article
26 days ago Oct 27, 2026
FDA.gov MedWatch Safety Alerts

Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues

SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resu

compounded
32 days ago Oct 21, 2026
PubMed Research

Innovative Treatments for Obstructive Sleep Apnea.

Neurol Clin • Tirzepatide • Journal Article

TirzepatideJournal ArticleReview
32 days ago Oct 21, 2026
PubMed Research

GLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study.

Int J Cardiol • Tirzepatide • Journal Article

TirzepatideSemaglutideJournal ArticleMulticenter Study
36 days ago Oct 17, 2026
PubMed Research

The pharmacotherapy for pediatric obesity: insights and challenges from adult weight-loss medications.

J Diabetes Metab Disord • Retatrutide • Journal Article

RetatrutideJournal ArticleReview
41 days ago Oct 12, 2026
ClinicalTrials.gov Trials

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

RECRUITING • Massachusetts General Hospital

INTERVENTIONALRECRUITINGTesamorelin
187 days ago May 19, 2026

This page is built from a generated JSON snapshot refreshed by scheduled syncs, not from a live browser request. FDA items come from RSS feeds, PubMed items come from NCBI utilities, and study updates come from the ClinicalTrials.gov API. The page is date-ordered for readability, while the underlying generator still scores relevance for homepage surfacing and future editorial modules.